Abstract:Quantitative or qualitative characterization of the drug-like features of known drugs may help medicinal and computational chemists to select higher quality drug leads from a huge pool of compounds and to improve the efficiency of drug design pipelines. For this purpose, the theoretical models for drug-likeness to discriminate between drug-like and non-drug-like based on molecular physicochemical properties and structural fingerprints were developed by using the naive Bayesian classification (NBC) and recursive partitioning (RP) techniques, and then the drug-likeness of the compounds from the Traditional Chinese Medicine Compound Database (TCMCD) was evaluated. First, the impact of molecular physicochemical properties and structural fingerprints on the prediction accuracy of drug-likeness was examined. We found that, compared with simple molecular properties, structural fingerprints were more essential for the accurate prediction of drug-likeness. Then, a variety of Bayesian classifiers were constructed by changing the ratio of drug-like to non-drug-like molecules and the size of the training set. The results indicate that the prediction accuracy of the Bayesian classifiers was closely related to the size and the degree of the balance of the training set. When a balanced training set was used, the best Bayesian classifier based on 21 physicochemical properties and the LCFP_6 fingerprint set yielded an overall leave-one-out (LOO) cross-validated accuracy of 91.4% for the 140,000 molecules in the training set and 90.9% for the 40,000 molecules in the test set. In addition, the RP classifiers with different maximum depth were constructed and compared with the Bayesian classifiers, and we found that the best Bayesian classifier outperformed the best RP model with respect to overall prediction accuracy. Moreover, the Bayesian classifier employing structural fingerprints highlights the important substructures favorable or unfavorable for drug-likeness, offering extra valuable information for getting high quality lead compounds in the early stage of the drug design/discovery process. Finally, the best Bayesian classifier was used to predict the drug-likeness of 33,961 compounds in TCMCD. Our calculations show that 59.37% of the molecules in TCMCD were identified as drug-like molecules, indicating that traditional Chinese medicines (TCMs) are therefore an excellent source of drug-like molecules. Furthermore, the important structural fingerprints in TCMCD were detected and analyzed. Considering that the pharmacology of TCMCD and MDDR (MDL Drug Data Report) was linked by the important common structural features, the potential pharmacology of the compounds in TCMCD may therefore be annotated by these important structural signatures identified from Bayesian analysis, which may be valuable to promote the development of TCMs.

Predicting ligand druggability for drug discovery

The Application of in Silico Drug-Likeness Predictions in Pharmaceutical Research.

Binding site detection and druggability prediction of protein targets for structure-based drug design.

Current Advances in Ligand‐based Target Prediction

DBPP-Predictor: a novel strategy for prediction of chemical drug-likeness based on property profiles

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

A practical view of ‘druggability’

Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery

DOCKSTRING: Easy Molecular Docking Yields Better Benchmarks for Ligand Design

Synthesis and Photo Electrochemical Characterization of an Extended π-Conjugated Heteroleptic Ruthenium (II) Complex

Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches

Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins.

Use of Natural Products As Chemical Library for Drug Discovery and Network Pharmacology

Current Trends and Challenges in Drug-Likeness Prediction: Are They Generalizable and Interpretable?

Statistical Learning Approach for Predicting Specific Pharmacodynamic, Pharmacokinetic, or Toxicological Properties of Pharmaceutical Agents

Prediction of Potential Toxicity and Side Effect Protein Targets of a Small Molecule by a Ligand–protein Inverse Docking Approach

Towards Cheminformatics-Based Estimation of Drug Therapeutic Index: Predicting the Protective Index of Anticonvulsants Using a New Quantitative Structure-Index Relationship Approach.

Drug-likeness Analysis of Traditional Chinese Medicines: Prediction of Drug-Likeness Using Machine Learning Approaches.

The prediction of protein–ligand unbinding for modern drug discovery

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis.